Evox Therapeutics to advance gene therapy for treatment of heart disease
Evox Therapeutics, an exosome therapeutics company, has announced a research collaboration and option agreement with the Icahn School of Medicine at Mount Sinai in New York, US.
Source: biopharma-reporter.com